cytochrome P450 3A4 epoxygenase inhibitors (University of California Irvine/University of Minnesota)

N/A

Report date: 2025/03/19 11:39:43
NME

Base Information

Drug Namecytochrome P450 3A4 epoxygenase inhibitors (University of California Irvine/University of Minnesota)
Drug Alias NameCYP3A4 epoxygenase inhibitors (University of California Irvine/University of Minnesota)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCytochrome P450 3A4 inhibitors
TargetsCytochrome P450 3A4
Therapy Area/IndicationsObesityDiabetes Mellitus, Type 2Breast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity of California Irvine
China Registration ClassN/A

Develop Information

Active CompaniesUniversity of California IrvineUniversity Of CaliforniaUniversity Of Minnesota
Inactive CompaniesN/A
Active IndicationsObesityDiabetes Mellitus, Type 2Breast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A